Association For Molecular Pathology et al v. United States Patent and Trademark Office et al

Filing 150

NOTICE OF APPEARANCE by Brian Michael Poissant on behalf of Lorris Betz, Roger Boyer, Jack Brittain, Arnold B. Combe, Raymond Gesteland, James U. Jensen, John Kendall Morris, Thomas Parks, David W. Pershing, Michael K. Young, Myriad Genetics, Inc. (Poissant, Brian)

Association For Molecular Pathology et al v. United States Patent and Trademark Office et al

Doc. 150

UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF NEW YORK ASSOCIATION FOR MOLECULAR PATHOLOGY; AMERICAN COLLEGE OF MEDICAL GENETICS; AMERICAN SOCIETY FOR CLINICAL PATHOLOGY; COLLEGE OF AMERICAN PATHOLOGISTS; HAIG KAZAZIAN, MD; ARUPA GANGULY, PhD; WENDY CHUNG, MD, PhD; HARRY OSTRER, MD; DAVID LEDBETTER, PhD; STEPHEN WARREN, PhD; ELLEN MATLOFF, M.S.; ELSA REICH, M.S.; BREAST CANCER ACTION; BOSTON WOMEN'S HEALTH BOOK COLLECTIVE; LISBETH CERIANI; RUNI LIMARY; GENAE GIRARD; PATRICE FORTUNE; VICKY THOMASON; KATHLEEN RAKER, Plaintiffs, v. UNITED STATES PATENT AND TRADEMARK OFFICE; MYRIAD GENETICS; LORRIS BETZ, ROGER BOYER, JACK BRITTAIN, ARNOLD B. COMBE, RAYMOND GESTELAND, JAMES U. JENSEN, JOHN KENDALL MORRIS, THOMAS PARKS, DAVID W. PERSHING, and MICHAEL K. YOUNG, in their official capacity as Directors of the University of Utah Research Foundation, Defendants. ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) )

Civil Action No. 09-4515 (RWS) NOTICE OF APPEARANCE

PLEASE TAKE NOTICE that Brian M. Poissant enters his appearance in this matter as counsel for defendant Myriad Genetics, Inc., named herein as Myriad Genetics, and for defendants Lorris Betz, Roger Boyer, Jack Brittain, Arnold B. Combe, Raymond Gesteland, James U. Jensen, John Kendall Morris, Thomas Parks, David W. Pershing, and Michael K. Young.

NYI-4240751v1

Dockets.Justia.com

Dated: New York, New York December 22, 2009 By:

Respectfully submitted, /s/ Brian M. Poissant Brian M. Poissant (BP2350) JONES DAY 222 East 41st Street New York, NY 10017-6702 (212) 326-33838 [e-mail]

NYI-4240751v1